NP47825 Multiple Sclerosis Medicines
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-04ce0632014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
9
Lots
2
2 awarded
Published
02 May 2025
Description
Supply of multiple sclerosis medicines to NHS Scotland.
Scope
- Reference
- ocds-h6vhtk-04ce06
- Commercial tool
- Standalone contract
- Contract dates
The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Technical (Supply Chain) | 5 | quality | — |
| — | 95 | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 2 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 2 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab | £49.3m | cancelled |
| 2 | Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules | £2.2m | cancelled |